Anti-MOG antibody-positive ADEM following infectious mononucleosis due to a primary EBV infection: a case report

Anti-Myelin oligodendrocyte glycoprotein (MOG) antibodies are detected in various demyelinating diseases, such as pediatric acute disseminated encephalomyelitis (ADEM), recurrent optic neuritis, and aquaporin-4 antibody-seronegative neuromyelitis optica spectrum disorder. We present a patient who de...

Full description

Saved in:
Bibliographic Details
Published inBMC neurology Vol. 17; no. 1; p. 76
Main Authors Nakamura, Yoshitsugu, Nakajima, Hideto, Tani, Hiroki, Hosokawa, Takafumi, Ishida, Shimon, Kimura, Fumiharu, Kaneko, Kimihiko, Takahashi, Toshiyuki, Nakashima, Ichiro
Format Journal Article
LanguageEnglish
Published England BioMed Central 19.04.2017
BMC
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Anti-Myelin oligodendrocyte glycoprotein (MOG) antibodies are detected in various demyelinating diseases, such as pediatric acute disseminated encephalomyelitis (ADEM), recurrent optic neuritis, and aquaporin-4 antibody-seronegative neuromyelitis optica spectrum disorder. We present a patient who developed anti-MOG antibody-positive ADEM following infectious mononucleosis (IM) due to Epstein-Barr virus (EBV) infection. A 36-year-old healthy man developed paresthesia of bilateral lower extremities and urinary retention 8 days after the onset of IM due to primary EBV infection. The MRI revealed the lesions in the cervical spinal cord, the conus medullaris, and the internal capsule. An examination of the cerebrospinal fluid revealed pleocytosis. Cell-based immunoassays revealed positivity for anti-MOG antibody with a titer of 1:1024 and negativity for anti-aquaporin-4 antibody. His symptoms quickly improved after steroid pulse therapy followed by oral betamethasone. Anti-MOG antibody titer at the 6-month follow-up was negative. This case suggests that primary EBV infection would trigger anti-MOG antibody-positive ADEM. Adult ADEM patients can be positive for anti-MOG antibody, the titers of which correlate well with the neurological symptoms.
Bibliography:ObjectType-Case Study-2
SourceType-Scholarly Journals-1
ObjectType-Feature-4
content type line 23
ObjectType-Report-1
ObjectType-Article-3
ISSN:1471-2377
1471-2377
DOI:10.1186/s12883-017-0858-6